Skip to main content
  • Journal Highlights

    Eye Shields for NFL Players, COVID-19’s Impact on Vision Scientists, and More


    Demographic and Clinical Features of MIGS Recipients

    Pegcetacoplan Carries Risk of New Exudation

    Eye Shields for NFL Players

    Ophthalmology Retina

    MEWDS Misdiagnosis Is Common

    American Journal of Ophthalmology

    Return to OR After RD Repair: Revisiting the 45-Day Metric

    Screen Use and Meibomian Gland Atrophy in Children

    JAMA Ophthalmology

    COVID-19’s Potential Impact on Vision Scientists

    Sequential Bilateral Cataract Surgery and Refractive Outcomes

    ICD-10 Codes for Uveitis: EHR Discrepancies

    Other Journals

    SARS-CoV-2: RNA Genomics in Ocular Specimens

    Outcomes of RRD Repair

    IRIS Registry Data Snapshot: Patient Visits During the Pandemic

    On March 18, 2020, the Academy sent a recommendation to “cease providing any treatment other than urgent or emergent care immediately” via email to members. In the month following that email, patient visits declined by more than 70% compared with baseline.

    To assess the impact of the COVID-19 pandemic on pa­tient care and outcomes, Leng et al. evaluated data from the IRIS Registry. Their earlier analysis covered January through August 2020.1 A new snapshot (right) updates their findings with data through December 2020. By mid-June, patient visits stabilized to 85%-95% of baseline, representing a substantial but not full recovery, possibly because vaccines were not available until the end of the year.


    1 Leng T et al. Ophthalmology. Published online June 15, 2021.

    COVID Impact
    COVID IMPACT. Daily weekday (nonholiday) patient visit volume during 2020. Secondary y-axis shows visit volume compared to a baseline from Jan. 1 to March 17, 2020. Note: The Academy has partnered with Verana Health to curate and analyze IRIS Registry data.